U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07483255) titled 'A Phase II Trial of Fetal Embolization for Vein of Galen Malformation' on March 12.
Brief Summary: This is a prospective, single-arm non-randomized interventional study of fetuses to assess the efficacy and safety of fetal embolization of VOGM. Subjects will receive a one-time study intervention of fetal embolization, at or after 34 weeks of gestation. After delivery, neurological assessments will be performed every 6 months for 2 years (adjusted for gestational age). Data will be compared to historical cohorts.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Vein of Galen Malformations
Intervention:
DEVICE:...